First-in-human phase 1 study of pimicotinib (ABSK021), a CSF-1R inhibitor, in patients with advanced solid tumors.
- Resource Type
- Article
- Authors
- Falchook, Gerald Steven; Liang, Yan; Harvey, R. Donald; Fu, Siqing; Weitao, Yao; Qin, Yan-ru; Zhang, Xiaojing; Henry, Jason Timothy; Zou, Qingping; Shan, Boyao; Liang, Pan; Wang, Chen; Li, Wenjia; Pamuklar, Zehra Nurgul; Pei, Yi; Chang, Zhiwei; Wang, Jiaqiang; Piha-Paul, Sarina A.; Bhave, Manali A.; Yin, Yongmei
- Source
- Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p3100-3100, 1p
- Subject
- Language
- ISSN
- 0732183X